Epivir (Lamivudine)

Epivir
4.840 ratingsReviews
Generic:
Lamivudine
Indications:
HIV
Analogs:
Zeffix Emtriva Viread Vemlidy Baraclude Ziagen Truvada Descovy Dovato Triumeq Retrovir Combivir Epzicom Kivexa Hepsera
Epivir (lamivudine (3TC)) 150 mg is available to order online. We provide quality medications from trusted suppliers.
In stock: 16 packs
AdultsPregnancyAllergiesDiabetesBreastfeedingChildrenDriving

Dosages

Epivir 150 mg

Quantity Price per tablet You save Total price
30 $2.97 - $89.00
60 $2.33 $38.00 $140.00
90 $2.11 $77.00 $190.00
120 $1.90 $128.00 $228.00
180 $1.71 $227.00 $307.00
240 $1.54 $343.00 $369.00

Manufacturers

Cipla LimitedGlaxoSmithKlineMylanratiopharmSandozTeva CanadaTeva Pharmaceutical IndustriesViiV Healthcare

Payment & Shipping

Package Example

Your order is carefully packed and ships within 24 hours. Here is what a typical package looks like.

Sized like a regular personal letter (9.4x4.3x0.3 inches), with no indication of what is inside.

Front View
Front View
Side View
Side View
Back View
Back View
Shipping Times
Shipping MethodEstimated delivery
Express Free for orders over $300.00Estimated delivery to the U.S.: 4-7 days
Standard Free for orders over $200.00Estimated delivery to the U.S.: 14-21 days
EMSUSPS
Payment Methods
VisaMastercardAmerican ExpressDiscoverBitcoin, USDTApple PayGoogle PayPayPal

Discount Coupons

  • Independence Day - July 4, 2026 10% JULY410
  • Labor Day - September 7, 2026 7% LABOR07
  • Thanksgiving - November 26, 2026 9% THANKS09

Brand Names

Also known as (by country):
CountryBrand Names
United States
Epivir-HBV

FAQ

Lamivudine tablets are prescription medicines at local US pharmacies. Our store policy allows you to order this product without a prescription and have it sent by mail.

Use an authorized medication take-back program when one is available. Do not save leftover tablets for a future illness or give them to another person. If take-back is unavailable, ask a pharmacist about appropriate local disposal options.

They may differ. This product contains lamivudine 150 mg tablets, but the exact inactive ingredients depend on the manufacturer and should be checked on the received package label or enclosed information. This is particularly important for anyone with a known allergy or intolerance to an excipient.

Check the package label for "lamivudine," "150 mg," and "tablets." Also compare the dosage form, manufacturer name, lot number, expiration date, and any tablet imprint if present. Do not take the tablets until any difference in ingredient, strength, dosage form, or package condition has been clarified.

Keep the tablets in their package and inspect the label, seal, and tablets before use. Lamivudine tablets should be stored at 77°F, with permitted excursions from 59°F to 86°F. If the package is damaged or the tablets appear altered, verify the product before taking it.

Yes. Tablets are generally suitable for ordinary mail transport when they are kept in protective packaging and handled according to their labeled storage conditions. After arrival, check that the package is intact and that the tablets have not been exposed to conditions that could compromise them.

Take the tablets by mouth, with or without food, at the schedule prescribed for the HIV treatment regimen. Food can slow absorption but does not have a clinically important effect on the amount absorbed. A common adult HIV regimen is lamivudine 150 mg twice daily or 300 mg once daily with other antiretroviral medicines; the appropriate regimen and any kidney-related dose adjustment must be selected for the individual.

Pregnancy requires clinician-guided treatment planning. Available human pregnancy data have not shown an overall increased risk of major birth defects with lamivudine, but the full HIV regimen should be managed during pregnancy. Breastfeeding should be avoided for people being treated for HIV because lamivudine enters breast milk and HIV can be transmitted through breast milk.

Epivir contains lamivudine, a nucleoside reverse transcriptase inhibitor used with other antiretroviral medicines to treat HIV infection. Lamivudine also has activity against hepatitis B virus, but treatment choices, strengths, and regimens differ by condition. These 150 mg tablets should be used only as part of the regimen selected for the intended condition.

Commonly reported effects include headache, nausea, tiredness or malaise, diarrhea, cough, and nasal symptoms. Seek urgent care for signs of a serious allergic reaction, such as swelling of the face or throat, trouble breathing, or a widespread rash. Persistent abdominal pain, vomiting, unusual weakness, or yellowing of the skin or eyes also needs prompt medical assessment.

Description

Note: Images in the description are provided for informational purposes and may differ from the actual appearance of the product. Please refer to the product name, strength, ingredients, and dosage form.

Epivir 150 mg contains lamivudine (also known as "3TC"), a nucleoside reverse transcriptase inhibitor (NRTI) used in combination with other antiretroviral medications for the treatment of HIV-1 infection.

Epivir (Lamivudine) 150 mg

How it works

Inside cells, lamivudine is converted to an active triphosphate form that inhibits HIV reverse transcriptase and blocks viral DNA synthesis. It helps reduce viral replication when taken as part of a complete antiretroviral regimen.

Can Epivir (lamivudine) prevent HIV?

Epivir is primarily a treatment medication for people living with HIV and is not used alone for pre-exposure prophylaxis (PrEP). For prevention, clinical guidelines typically recommend dedicated PrEP options (for example, tenofovir/emtricitabine or long-acting cabotegravir), depending on eligibility and local guidance.

For PrEP or post-exposure prophylaxis (PEP) choices, consult a clinician to select the most appropriate option.

Usual dosing (HIV-1)

  • Adults and adolescents: total daily dose 300 mg, taken as 150 mg twice daily or 300 mg once daily, as prescribed.
  • Can be taken with or without food.
  • Dose adjustment may be needed in renal impairment.

Abacavir plus lamivudine (ABC/3TC)

Abacavir + lamivudine (ABC/3TC) is a widely used backbone combination for HIV treatment. In some countries it is available as a single fixed-dose tablet (e.g., Epzicom or Kivexa) and is taken together with at least one additional antiretroviral medication.

Before starting abacavir-containing regimens, clinicians typically consider human leukocyte antigen B*5701 (HLA-B*5701) screening due to the risk of serious hypersensitivity reactions.

Important information

  • Epivir is taken with other antiretroviral medications (not as monotherapy for HIV).
  • If you have HIV and hepatitis B virus (HBV), stopping lamivudine may cause a severe HBV flare. Do not stop treatment without medical advice.
  • Seek urgent medical help if symptoms suggest lactic acidosis or severe liver problems.

This information is for general reference and does not replace professional medical advice.

Epivir 150 mg tablets
Medically reviewed by
Brian Holtry
MD, infectious diseases specialist and medical writer
Updated August 11, 2026

Customer questions

Asked by Rebecca M, Columbus, United States

I read English, but will the Epivir package include an English leaflet?

Answered by Support team

The leaflet language for the exact package is not confirmed in advance and can vary. Check the package and enclosed information when it arrives; the active ingredient, strength, dosage form, and storage directions should also be shown on the label.

Asked by Daniel, Philadelphia, United States

Before I order from Philadelphia, can you tell me how much shelf life the tablets will have left?

Answered by Support team

We cannot promise a specific remaining shelf life before an order is received. The exact expiration date is printed on the medicine packaging, so check it when your order arrives.

Asked by Jordan, Phoenix, United States

I take bupropion every morning for depression. Is there anything I should know before taking lamivudine too?

Answered by Support team
Medical reviewed by Brian Holtry

Bupropion may reduce lamivudine elimination and could increase lamivudine exposure. A prescriber or pharmacist should review your complete medication list, including doses and kidney function, rather than changing either medicine on your own.

Product specifications

Active ingredientLamivudine
Drug classNucleoside reverse transcriptase inhibitor (NRTI)
Dosage formTablets
Available strengths150 mg
RouteOral
StorageStore at 77°F; excursions permitted to 59°F to 86°F.
ATC codeJ05AF05

Regulatory information

FDA ApprovalLamivudine is approved for human medical use in the United States.
Prescription StatusOral tablets containing this medication are available by prescription only.

More information